# CAR-T

1 posts.

- [Half of myeloma patients given one CAR-T infusion after an early relapse were progression-free five years on](https://healthcarenews.io/news/car-t-first-relapse-myeloma-five-year-results.md) (2026-11-11): CAR-T at first relapse in myeloma: Legend Biotech says half of 20 early-line CARVYKTI patients stayed progression-free five years after one infusion.